Cargando…

iPS Cells for Modelling and Treatment of Retinal Diseases

For many decades, we have relied on immortalised retinal cell lines, histology of enucleated human eyes, animal models, clinical observation, genetic studies and human clinical trials to learn more about the pathogenesis of retinal diseases and explore treatment options. The recent availability of p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Fred K., McLenachan, Samuel, Edel, Michael, Da Cruz, Lyndon, Coffey, Peter J., Mackey, David A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470196/ https://www.ncbi.nlm.nih.gov/pubmed/26237613 http://dx.doi.org/10.3390/jcm3041511

Ejemplares similares

Bioengineered Bruch's-like extracellular matrix promotes retinal pigment epithelial differentiation
por: McLenachan, Samuel, et al.
Publicado: (2017)

Protective Effects of Human iPS-Derived Retinal Pigment Epithelium Cell Transplantation in the Retinal Dystrophic Rat
por: Carr, Amanda-Jayne, et al.
Publicado: (2009)

Prospects for clinical use of reprogrammed cells for autologous treatment of macular degeneration
por: Alvarez Palomo, Ana Belen, et al.
Publicado: (2015)

Inherited Retinal Disease Therapies Targeting Precursor Messenger Ribonucleic Acid
por: Huang, Di, et al.
Publicado: (2017)

Mitochondrial Dysfunction and Impaired Antioxidant Responses in Retinal Pigment Epithelial Cells Derived from a Patient with RCBTB1-Associated Retinopathy
por: Huang, Zhiqin, et al.
Publicado: (2023)

Profiling the microRNA Expression in Human iPS and iPS-derived Retinal Pigment Epithelium
por: Wang, Heuy-Ching, et al.
Publicado: (2014)

mRNA Transfection of Mouse and Human Neural Stem Cell Cultures
por: McLenachan, Samuel, et al.
Publicado: (2013)

In vivo retinal imaging is associated with cognitive decline, blood-brain barrier disruption and neuroinflammation in type 2 diabetic mice
por: Majimbi, May, et al.
Publicado: (2023)

Beyond iPS!
Publicado: (2012)

iPS-Cell Technology and the Problem of Genetic Instability—Can It Ever Be Safe for Clinical Use?
por: Attwood, Stephen W., et al.
Publicado: (2019)

A Strategy for Personalized Treatment of iPS-Retinal Immune Rejections Assessed in Cynomolgus Monkey Models
por: Fujii, Shota, et al.
Publicado: (2020)

Myogenic Precursors from iPS Cells for Skeletal Muscle Cell Replacement Therapy
por: Roca, Isart, et al.
Publicado: (2015)

Inner Retinal Changes in Acute Experimental BRVO Treated With Bevacizumab or Triamcinolone Acetonide
por: McAllister, Ian L., et al.
Publicado: (2023)

Gene replacement therapy restores RCBTB1 expression and cilium length in patient‐derived retinal pigment epithelium
por: Huang, Zhiqin, et al.
Publicado: (2021)

Modeling Kidney Disease with iPS Cells
por: Freedman, Benjamin S.
Publicado: (2015)

Serum miRNA modulations indicate changes in retinal morphology
por: Aggio-Bruce, Riemke, et al.
Publicado: (2023)

Aging in iPS cells
por: Miller, Justine, et al.
Publicado: (2014)

Short-Term Parafoveal Cone Loss Despite Preserved Ellipsoid Zone in Rod Cone Dystrophy
por: Roshandel, Danial, et al.
Publicado: (2021)

Protective effects of human iPS-derived retinal pigmented epithelial cells on retinal degenerative disease
por: Zhu, Deliang, et al.
Publicado: (2020)

iPS cells generation: an overview of techniques and methods
por: Telpalo-Carpio, SA, et al.
Publicado: (2013)

Understanding the mysteries of iPS cells
por: Cohen, Justin Brent, et al.
Publicado: (2009)

Evolving science enhanced with iPS
Publicado: (2007)

iPS Cells—The Triumphs and Tribulations
por: Sharma, Riddhi
Publicado: (2016)

BAM15 attenuates transportation-induced apoptosis in iPS-differentiated retinal tissue
por: Tang, Mingjun, et al.
Publicado: (2019)

Ethanol-mediated activation of the NLRP3 inflammasome in iPS cells and iPS cells-derived neural progenitor cells
por: De Filippis, Lidia, et al.
Publicado: (2016)

Correction: Protective effects of human iPS-derived retinal pigmented epithelial cells on retinal degenerative disease
por: Zhu, Deliang, et al.
Publicado: (2022)

Incidence and mortality of uveal melanoma in Australia (1982–2014)
por: Beasley, Aaron B, et al.
Publicado: (2023)

Incidence and Mortality of Conjunctival Melanoma in Australia (1982 to 2014)
por: Beasley, Aaron B., et al.
Publicado: (2023)

An iPS‐derived in vitro model of human atrial conduction
por: Biendarra‐Tiegs, Sherri M., et al.
Publicado: (2022)

Editorial for Special Issue: iPS Cells (iPSCs) for Modelling and Treatment of Human Diseases
por: Graffmann, Nina, et al.
Publicado: (2022)

The Potential of iPS Cells in Synucleinopathy Research
por: Linta, Leonhard, et al.
Publicado: (2012)

The tumourigenicity of iPS cells and their differentiated derivates
por: Liu, Zhiqiang, et al.
Publicado: (2013)

iPS-Cinderella Story in Cell Biology
Publicado: (2010)

Questions Surrounding iPS Cells in Japan
por: Yui, Yoshiki
Publicado: (2016)

iPS‐derived pericytes for neurovascular regeneration
por: Kirabali, Tunahan, et al.
Publicado: (2021)

Establishment of LIF-Dependent Human iPS Cells Closely Related to Basic FGF-Dependent Authentic iPS Cells
por: Hirai, Hiroyuki, et al.
Publicado: (2012)

Treatment of Diabetes Mellitus Using iPS Cells and Spice Polyphenols
por: Ge, Qi, et al.
Publicado: (2017)

An HDAC2-TET1 switch at distinct chromatin regions significantly promotes the maturation of pre-iPS to iPS cells
por: Wei, Tingyi, et al.
Publicado: (2015)

Human iPS cell models of Jervell and Lange-Nielsen syndrome
por: Bellin, Milena, et al.
Publicado: (2015)

Telomere Reprogramming and Maintenance in Porcine iPS Cells
por: Ji, Guangzhen, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_qtt4lpf7u8bcsjppuk4b9vrvig